| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.07 | 0.6 |